Neuronetics, Inc.

STIM ·Healthcare, Medical Devices, United States
Financial Statements › Income Statement
Annual Quarterly

Income Statement

Line Item FY2017 FY2016
Revenue $40.4M $34.2M
Cost of Revenue $9.6M $6.6M
Gross Profit $30.8M $27.6M
Gross Margin 76.2% 80.7%
Operating Expenses
Research & Development $7.9M $8.2M
SG&A Expense $8.6M $6.9M
Operating Income $-13.6M $-9.3M
Operating Margin -33.7% -27.3%
Interest Expense $2.8M $1.8M
Pretax Income $-16.1M $-11.2M
Income Tax Expense — —
Net Income $-16.1M $-11.2M
Net Margin -39.7% -32.8%
EPS (Basic) $-43.17 $-38.48
EPS (Diluted) $-43.17 $-38.48
Shares Outstanding (Basic) 462.0K —
Shares Outstanding (Diluted) 462.0K —
Dividends Per Share — —
← Newer Page 2 of 2 Older →